\
&
Contact us
\
&
Contact us
Published on | 7 months ago
ProgrammesThe We Make Future initiative and the EIT manufacturing have launched the call for the future of manufacturing, AI & industry 4.0 challenge. This international call invites cutting-edge AI-driven startups to pioneer solutions across several key themes in the “future of manufacturing”, including industrial and generative AI, digital ecosystem integration, circular economy and resilient supply chains. With a focus that ranges from environmental issues to the ethical deployment of AI, the initiative encourages startups to address real-world industrial needs.
The call deadline is the 3rd of november 2025 and more information can found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
